Clinical Trials on Hepatitis Immune

Total 55530 results

University of California, San Francisco
Janssen Scientific Affairs, LLC

Withdrawn

A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C

Hepatitis C, Chronic | HIV CDC Category A1

United States
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

HIV Infections | Hepatitis C, Chronic | Hepacivirus
National Taiwan University Hospital

Completed

Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection

Hepatitis

Taiwan
Institut de Recherche pour le Developpement
Ministry of Health, Thailand

Completed

HCV-HIV Co-infected Patient Cohort in Thailand

HIV | Hepatitis C Infection

Thailand
Chiang Mai University

Unknown

HBV Vaccination in HIV-infected Adults

Hepatitis B Vaccination, HIV

Thailand
National Institutes of Health Clinical Center (CC)

Completed

A Controlled Prospective Study of Transfusion-Associated Hepatitis

Hepatitis

United States
Erasmus Medical Center
Public Health Service of Rotterdam-Rijnmond

Recruiting

Prevalence of HCV in HIV-negative MSM

Hepatitis C Virus Infection

Netherlands
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis (PRO-SURFASA)

Liver Failure, Acute | Hepatitis, Autoimmune | Risk Factors | Organ Dysfunction Scores

France
bioLytical Laboratories
St Vincent's Hospital Melbourne

Not yet recruiting

A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites

Hepatitis B | Hepatitis B Infection

Australia
bioLytical Laboratories

Recruiting

Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

Hepatitis B | Hepatitis B Infection

South Africa
Bristol-Myers Squibb

Terminated

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV (DIMENSION)

Chronic Hepatitis C Infection

France, Germany, United States, Spain, Canada, Argentina, Mexico, Belgium, Italy, Russian Federation, United Kingdom, Poland
Children's Hospital Medical Center, Cincinnati

Recruiting

MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease

Autoimmune Liver Disease | Primary Sclerosing Cholangitis | Autoimmune Hepatitis

United States
San Francisco Veterans Affairs Medical Center
Merck Sharp & Dohme LLC

Unknown

Hepatitis C (HCV) Cure and Kidney Health

Hepatitis C

United States
The HIV Netherlands Australia Thailand Research...

Completed

A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection

Hepatitis b Virus

Thailand
Rockefeller University

Terminated

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

HIV Infections | Hepatitis C Virus

United States
Imperial College London
Institut National de la Santé Et de la Recherche Médicale, France; Medical... and other collaborators

Completed

PROLIFICA - West African Treatment Cohort for Hepatitis B (WATCH)

Hepatocellular Carcinoma | Hepatitis B, Chronic

Gambia, Senegal
Centre Hospitalier Universitaire de Nice

Unknown

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population (EPIALHICE B)

HIV Infections | Pregnancy | Hepatitis C Virus

France
International Vaccine Institute
Bill and Melinda Gates Foundation; Xiamen Innovax Biotech Co., Ltd

Not yet recruiting

Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children

Hepatitis E Virus Infection
Myanmar Oxford Clinical Research Unit
Medical Action Myanmar; Myanmar Liver Foundation

Withdrawn

Hepatitis C Treatment Study in Myanmar

Hepatitis C

Myanmar
Peter J. Ruane, M.D., Inc.

Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection

Treatment of Hepatitis C

United States
University of Texas Southwestern Medical Center

Completed

Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients (VK)

Hepatitis C
Cairo University
University of California, Los Angeles; Daiwa Pharmaceutical Corporation Co,...

Completed

Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV

Hepatitis C, Chronic
National Institute of Allergy and Infectious Diseases...

Completed

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

HIV Infections | Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...

Completed

Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV

Hepatitis C | HIV

United States
Kirby Institute
Gilead Sciences; The University of New South Wales

Completed

Tenofovir in HIV/HBV Coinfection (TICO)

HIV Infection | Hepatitis B Coinfection

Australia, Thailand
Gilead Sciences

Completed

Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.

Hepatitis C | HIV

Puerto Rico
University of Colorado, Denver

Completed

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers

Hepatitis C | HIV

United States
The HIV Netherlands Australia Thailand Research...
Kirby Institute; Ministry of Health, Thailand

Completed

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

HIV | Hepatitis-B

Thailand
National Institute of Allergy and Infectious Diseases...

Completed

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

HIV Infections | Hepatitis C

United States
Nantes University Hospital

Completed

Study on the Prevalence of Hepatitis C In a psychiatRic Population (SaPHIR)

Hepatitis C

France
Vertex Pharmaceuticals Incorporated

Terminated

A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Hepatitis C

United States, Canada, Germany, Puerto Rico, Spain
Kirby Institute

Recruiting

Australian Hepatitis and Risk Survey in Prisons (AusHep)

HIV Infections | Hepatitis B | Hepatitis C

Australia
National Taiwan University Hospital

Recruiting

Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM

Viral Hepatitis C

Taiwan
National Institutes of Health Clinical Center (CC)

Completed

Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

HIV Infection | Hepatitis B | Hepatitis C

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Hepatitis | HIV/AIDS

United States
Children's Hospital Medical Center, Cincinnati

Recruiting

A-LiNK: Improving Outcomes in Autoimmune Liver Disease (ALINK)

Primary Sclerosing Cholangitis | Autoimmune Hepatitis

United States
Macfarlane Burnet Institute for Medical Research...
The Alfred

Completed

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals (co-EC)

Hepatitis C | HIV

Australia
ANRS, Emerging Infectious Diseases

Completed

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa (TAC)

HIV Infection | Hepatitis C

Cameroon, Côte D'Ivoire, Senegal
Johns Hopkins University
University of Colorado, Denver; GlaxoSmithKline

Completed

Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment

Hepatitis C | HIV

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light

Hepatitis C Virus
UMC Utrecht
Hoffmann-La Roche

Completed

Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

HIV Infections | Hepatitis C

Netherlands
National Center for Research Resources (NCRR)
Tulane University School of Medicine

Completed

Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

Hepatitis C
Hasselt University
University Ghent

Completed

HBV/HCV/HIV in Belgian Prisons

HIV Infections | Hepatitis B | Hepatitis C

Belgium
Centre de Recherches et d'Etude sur la Pathologie...

Completed

Pilot Study of HIV and Hepatitis B and C Screening in Surgery (OPDEP)

HIV Infections | Hepatitis B | Hepatitis C

France
University of California, San Francisco
National Institutes of Health Clinical Center (CC); Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID) and other collaborators

Completed

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant (STOP-CO)

Hepatitis C | HIV | Cirrhosis

United States
Bristol-Myers Squibb

Completed

A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Hepatitis C

United States
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Completed

Effects of HIV and Hepatitis C Virus on the Brain

HIV Infections | Hepatitis C

United States
University of Cincinnati
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV (ART and HCV)

HIV Infections | Hepatitis C

United States
St. James's Hospital, Ireland

Unknown

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

HIV Infections | Hepatitis C

Ireland
Pfizer

Completed

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

HIV Infection | Hepatitis C

Canada, United States

Clinical Trials on Hepatitis Immune

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations